干细胞
干细胞疗法
医学
移植
细胞疗法
生物信息学
重症监护医学
生物
内科学
细胞生物学
作者
Jing Wang,Qun Li,Wenbo Li,Nahúm Méndez‐Sánchez,Xiaofeng Liu,Xingshun Qi
标识
DOI:10.31083/j.fbl2812359
摘要
Stem cell therapy offers a promising avenue for advanced liver disease cases as an alternative to liver transplantation. Clinical studies are underway to explore the potential of stem cells from various sources in treating different liver diseases. However, due to the variability among current studies, further validation is needed to ensure the safety and effectiveness of stem cell therapy. To establish a strong foundation for optimal stem cell therapy applications, selection of suitable stem cell sources, standardization of transplantation protocols, and patient criteria are vital. This review comprehensively examines existing literature on stem cell sources, transplantation methods, and patient selection. Additionally, we discuss novel strategies, including stem cell preconditioning, cell-free therapy, genetic modification of stem cells, and the use of liver organoids, addressing the limitations of current stem cell therapies. Nevertheless, these innovative approaches require further validation.
科研通智能强力驱动
Strongly Powered by AbleSci AI